UBS Group AG - INDAPTUS THERAPEUTICS INC ownership

INDAPTUS THERAPEUTICS INC's ticker is and the CUSIP is 45339J105. A total of 18 filers reported holding INDAPTUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INDAPTUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$377
-69.1%
137
-78.6%
0.00%
Q2 2023$1,222
-90.6%
640
-80.6%
0.00%
Q1 2022$13,000
-53.6%
3,294
-33.2%
0.00%
Q4 2021$28,000
+2700.0%
4,932
+3636.4%
0.00%
Q3 2021$1,0001320.00%
Other shareholders
INDAPTUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
STRATEGY ASSET MANAGERS LLC 45,336$124,9010.03%
Vivaldi Capital Management LP 24,000$66,1200.02%
INVESTMENT HOUSE LLC 102,849$283,3490.02%
Pine Valley Investments Ltd Liability Co 44,240$121,8820.01%
UBS Group AG 137$3770.00%
WELLS FARGO & COMPANY/MN 102$2810.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 7$190.00%
GEODE CAPITAL MANAGEMENT, LLC 54,767$148,9920.00%
STATE STREET CORP 19,473$52,9670.00%
View complete list of INDAPTUS THERAPEUTICS INC shareholders